NEW YORK – Ubiquitome said on Monday that it has signed an exclusive agreement with Switzerland-based market expansion services group DiethelmKellerSiberHegner (DKSH) to market and sell Ubiquitome's mobile PCR-based COVID-19 testing platform Liberty16 in several countries in the Asia-Pacific region.